- Home
- AUTL vs ACIC Comparison
AUTL vs ACIC Comparison
Compare AUTL & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.41
Company Overview
Basic Information| Metric | AUTL | ACIC |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United Kingdom | United States |
| Employees | N/A | 68 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.2M | 538.1M |
| IPO Year | 2025 | 2007 |
Fundamental Metrics
Financial Performance| Metric | AUTL | ACIC |
|---|---|---|
| Price | $1.41 | $11.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 244.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 6.78% |
| EPS Growth | 28.33 | ★ 39.61 |
| EPS | N/A | ★ 2.15 |
| Revenue | $10,120,000.00 | ★ $335,439,000.00 |
| Revenue This Year | $669.62 | N/A |
| Revenue Next Year | $79.78 | $1.00 |
| P/E Ratio | ★ N/A | $5.15 |
| Revenue Growth | ★ 496.00 | 13.07 |
| 52 Week Low | $1.11 | $9.97 |
| 52 Week High | $2.70 | $13.06 |
Technical Indicators
Market Signals| Indicator | AUTL | ACIC |
|---|---|---|
| Relative Strength Index (RSI) | 41.88 | 52.35 |
| Support Level | $1.27 | $10.97 |
| Resistance Level | $1.52 | $11.85 |
| Average True Range (ATR) | 0.08 | 0.27 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 14.29 | 54.23 |
Price Performance
Historical Comparison AUTL
ACIC
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.